drugset / Trial / NCT06191523

The Effect of Melatonin as an Adjuvant Therapy for Preterm Neonates With Sepsis

NCT06191523

Completed 42 enrolled Universitas Sebelas Maret
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The goal of this clinical trial is to assess the effect of melatonin on MDA serum, IL-6, IL-8 levels, ANC, and sepsis score in preterm neonates with sepsis. The main question aim to answer : • Does melatonin affect MDA serum, IL-6, IL-8 levels, ANC, and sepsis score in preterm neonates with sepsis? The participants in the treatment group will receive a single dose of oral melatonin 20 mg, meanwhile those the control group will receive placebo. The researchers will compare MDA serum, IL-6, IL-8 levels, ANC, and sepsis score before and after receiving melatonin, whether there are decreases of MDA serum, IL-6, IL-8 levels, ANC and increase of sepsis score

Timeline

Start
2023-04-27
Primary completion
2023-10-05
Completion
2023-10-20

Drugs

EvaluationDrugModalityDoseRoute
Subject Melatonin Small molecule 20 mg Oral

Indications